Dynacure S.A. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Dynacure S.A. | DYCU - NASDAQ |
Withdrawn | $0.00 | $0.00 | Withdrawn | 7/16/2021 |
| J.P. Morgan, BofA Securities, Wells Fargo Securities | ||||||
Co-Manager(s): Needham & Company
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-25 Terms Added 2021-07-12 | ||||||
About Dynacure S.A. (adapted from Dynacure S.A. prospectus):
They are a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "DYCU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.